The GLP-1 agonist class dominates peptide drug revenue, with tirzepatide (Mounjaro/Zepbound) rapidly gaining market share as a dual-agonist alternative
A: You can request samples directly from the supplier for preliminary evaluation before placing a bulk order
Polmacoxib is an orally active dual inhibitor of COX-2 and carbonic anhydrase (CA)
BPC-157 BPC-157 GHK-Cu (Copper Peptide) GHK-Cu (Copper Peptide) TB-500 TB-500 Together, these peptides deliver the ReSpa GLOW effect boosting cellular repair, metabolism, and natural radiance from the inside out
Healthcare practitioner channels, fitness centers, dermatology programs, longevity clinics, and e-commerce subscription platforms are accelerating market penetration, reinforcing the shift toward clean-label, clinically validated, and compliance-focused nutraceutical models